COVID-19 Impact on Non-Invasive Cancer Diagnostics Market, Global Research Reports 2020-2021


This report covers market size and forecasts of Non-Invasive Cancer Diagnostics, including the following market information:
    Global Non-Invasive Cancer Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
    Global Non-Invasive Cancer Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
    Global Non-Invasive Cancer Diagnostics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
    Global Non-Invasive Cancer Diagnostics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include Gen-Probe Inc, Digene Corporation, Quest Diagnostics Inc, Cancer, Genetics Inc, BIOVIEW Inc, AVIVA Biosciences Corporation, Laboratory Corporation of America Holdings (LabCorp), A&G Pharmaceutical, Affymetrix Inc, Precision Therapeutics, etc.

Based on the Region:
    Asia-Pacific (China, Japan, South Korea, India and ASEAN)
    North America (US and Canada)
    Europe (Germany, France, UK and Italy)
    Rest of World (Latin America, Middle East & Africa)

Based on the Type:
    CTCs
    CTNAS
    Exosomes

Based on the Application:
    Blood
    Urine
    Saliva
1.1 Research Scope
    1.2 Market Segmentation
    1.3 Research Objectives
    1.4 Research Methodology
        1.4.1 Research Process
        1.4.2 Data Triangulation
        1.4.3 Research Approach
        1.4.4 Base Year
    1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
        1.5.2 Covid-19 Impact: Commodity Prices Indices
        1.5.3 Covid-19 Impact: Global Major Government Policy
    1.6 The Covid-19 Impact on Non-Invasive Cancer Diagnostics Industry
    1.7 COVID-19 Impact: Non-Invasive Cancer Diagnostics Market Trends

2 Global Non-Invasive Cancer Diagnostics Quarterly Market Size Analysis
    2.1 Non-Invasive Cancer Diagnostics Business Impact Assessment - COVID-19
        2.1.1 Global Non-Invasive Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    2.2 Global Non-Invasive Cancer Diagnostics Quarterly Market Size 2020-2021
    2.3 COVID-19-Driven Market Dynamics and Factor Analysis
        2.3.1 Drivers
        2.3.2 Restraints
        2.3.3 Opportunities
        2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020
    3.1 By Players, Global Non-Invasive Cancer Diagnostics Quarterly Market Size, 2019 VS 2020
    3.2 By Players, Non-Invasive Cancer Diagnostics Headquarters and Area Served
    3.3 Date of Key Players Enter into Non-Invasive Cancer Diagnostics Market
    3.4 Key Players Non-Invasive Cancer Diagnostics Product Offered
    3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Non-Invasive Cancer Diagnostics Segments, By Type
    4.1 Introduction
        1.4.1 CTCs
        1.4.2 CTNAS
        1.4.3 Exosomes
    4.2 By Type, Global Non-Invasive Cancer Diagnostics Market Size, 2019-2021

5 Impact of Covid-19 on Non-Invasive Cancer Diagnostics Segments, By Application
    5.1 Overview
        5.5.1 Blood
        5.5.2 Urine
        5.5.3 Saliva
    5.2 By Application, Global Non-Invasive Cancer Diagnostics Market Size, 2019-2021
        5.2.1 By Application, Global Non-Invasive Cancer Diagnostics Market Size by Application, 2019-2021

6 Geographic Analysis
    6.1 Introduction
    6.2 North America
        6.2.1 Macroeconomic Indicators of US
        6.2.2 US
        6.2.3 Canada
    6.3 Europe
        6.3.1 Macroeconomic Indicators of Europe
        6.3.2 Germany
        6.3.3 France
        6.3.4 UK
        6.3.5 Italy
    6.4 Asia-Pacific
        6.4.1 Macroeconomic Indicators of Asia-Pacific
        6.4.2 China
        6.4.3 Japan
        6.4.4 South Korea
        6.4.5 India
        6.4.6 ASEAN
    6.5 Rest of World
        6.5.1 Latin America
        6.5.2 Middle East and Africa

7 Company Profiles
    7.1 Gen-Probe Inc
        7.1.1 Gen-Probe Inc Business Overview
        7.1.2 Gen-Probe Inc Non-Invasive Cancer Diagnostics Quarterly Revenue, 2020
        7.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Product Introduction
        7.1.4 Gen-Probe Inc Response to COVID-19 and Related Developments
    7.2 Digene Corporation
        7.2.1 Digene Corporation Business Overview
        7.2.2 Digene Corporation Non-Invasive Cancer Diagnostics Quarterly Revenue, 2020
        7.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Product Introduction
        7.2.4 Digene Corporation Response to COVID-19 and Related Developments
    7.3 Quest Diagnostics Inc
        7.3.1 Quest Diagnostics Inc Business Overview
        7.3.2 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Quarterly Revenue, 2020
        7.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product Introduction
        7.3.4 Quest Diagnostics Inc Response to COVID-19 and Related Developments
    7.4 Cancer, Genetics Inc
        7.4.1 Cancer, Genetics Inc Business Overview
        7.4.2 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Quarterly Revenue, 2020
        7.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product Introduction
        7.4.4 Cancer, Genetics Inc Response to COVID-19 and Related Developments
    7.5 BIOVIEW Inc
        7.5.1 BIOVIEW Inc Business Overview
        7.5.2 BIOVIEW Inc Non-Invasive Cancer Diagnostics Quarterly Revenue, 2020
        7.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Product Introduction
        7.5.4 BIOVIEW Inc Response to COVID-19 and Related Developments
    7.6 AVIVA Biosciences Corporation
        7.6.1 AVIVA Biosciences Corporation Business Overview
        7.6.2 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Quarterly Revenue, 2020
        7.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product Introduction
        7.6.4 AVIVA Biosciences Corporation Response to COVID-19 and Related Developments
    7.7 Laboratory Corporation of America Holdings (LabCorp)
        7.7.1 Laboratory Corporation of America Holdings (LabCorp) Business Overview
        7.7.2 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Quarterly Revenue, 2020
        7.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product Introduction
        7.7.4 Laboratory Corporation of America Holdings (LabCorp) Response to COVID-19 and Related Developments
    7.8 A&G Pharmaceutical
        7.8.1 A&G Pharmaceutical Business Overview
        7.8.2 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Quarterly Revenue, 2020
        7.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Product Introduction
        7.8.4 A&G Pharmaceutical Response to COVID-19 and Related Developments
    7.9 Affymetrix Inc
        7.9.1 Affymetrix Inc Business Overview
        7.9.2 Affymetrix Inc Non-Invasive Cancer Diagnostics Quarterly Revenue, 2020
        7.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Product Introduction
        7.9.4 Affymetrix Inc Response to COVID-19 and Related Developments
    7.10 Precision Therapeutics
        7.10.1 Precision Therapeutics Business Overview
        7.10.2 Precision Therapeutics Non-Invasive Cancer Diagnostics Quarterly Revenue, 2020
        7.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Product Introduction
        7.10.4 Precision Therapeutics Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix
    9.1 About US
    9.2 Disclaimer

List of Tables Table 1. Overview of the World Economic Outlook Projections Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 7. Covid-19 Impact: Global Major Government Policy Table 8. The Covid-19 Impact on Non-Invasive Cancer Diagnostics Assessment Table 9. COVID-19 Impact: Non-Invasive Cancer Diagnostics Market Trends Table 10. COVID-19 Impact Global Non-Invasive Cancer Diagnostics Market Size Table 11. Global Non-Invasive Cancer Diagnostics Quarterly Market Size, 2020 (US$ Million) Table 12. Global Non-Invasive Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million) Table 13. Global Non-Invasive Cancer Diagnostics Market Growth Drivers Table 14. Global Non-Invasive Cancer Diagnostics Market Restraints Table 15. Global Non-Invasive Cancer Diagnostics Market Opportunities Table 16. Global Non-Invasive Cancer Diagnostics Market Challenges Table 17. By Players, Non-Invasive Cancer Diagnostics Quarterly Revenue, 2019 VS 2020 (US$ Million) Table 18. Key Players, Non-Invasive Cancer Diagnostics Revenue Market Share, 2019 VS 2020 (%) Table 19. Key Non-Invasive Cancer Diagnostics Players Headquarters and Area Served Table 20. Date of Key Players Enter into Non-Invasive Cancer Diagnostics Market Table 21. Key Players Non-Invasive Cancer Diagnostics Product Type Table 22. Mergers & Acquisitions, Expansion Plans Table 23. By Players, Global Non-Invasive Cancer Diagnostics Market Size 2019-2021, (US$ Million) Table 24. Global Non-Invasive Cancer Diagnostics Market Size by Application: 2019-2021 (US$ Million) Table 25. Global Non-Invasive Cancer Diagnostics Market Size by Region, 2019-2021 (US$ Million) Table 26. By Country, North America Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 27. By Type, US Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 28. By Application, US Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 29. By Type, Canada Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 30. By Application, Canada Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy) Table 32. By Country, Europe Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 33. By Type, Germany Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 34. By Application, Germany Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 35. By Type, France Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 36. By Application, France Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 37. By Type, UK Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 38. By Application, UK Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 39. By Type, Italy Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 40. By Application, Italy Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN) Table 42. By Region, Asia-Pacific Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 43. By Type, China Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 44. By Application, China Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 45. By Type, Japan Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 46. By Application, Japan Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 47. By Type, South Korea Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 48. By Application, South Korea Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 49. By Type, India Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 50. By Application, India Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 51. By Type, ASEAN Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 52. By Application, ASEAN Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 53. By Type, Latin America Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 54. By Application, Latin America Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 55. By Type, Middle East and Africa Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 56. By Application, Middle East and Africa Non-Invasive Cancer Diagnostics Market Size, 2019-2021 (US$ Million) Table 57. Gen-Probe Inc Business Overview Table 58. Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 59. Gen-Probe Inc Non-Invasive Cancer Diagnostics Product Table 60. Gen-Probe Inc Response to COVID-19 and Related Developments Table 61. Digene Corporation Business Overview Table 62. Digene Corporation Non-Invasive Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 63. Digene Corporation Non-Invasive Cancer Diagnostics Product Table 64. Digene Corporation Response to COVID-19 and Related Developments Table 65. Quest Diagnostics Inc Business Overview Table 66. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 67. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product Table 68. Quest Diagnostics Inc Response to COVID-19 and Related Developments Table 69. Cancer, Genetics Inc Business Overview Table 70. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 71. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product Table 72. Cancer, Genetics Inc Response to COVID-19 and Related Developments Table 73. BIOVIEW Inc Business Overview Table 74. BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 75. BIOVIEW Inc Non-Invasive Cancer Diagnostics Product Table 76. BIOVIEW Inc Response to COVID-19 and Related Developments Table 77. AVIVA Biosciences Corporation Business Overview Table 78. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 79. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product Table 80. AVIVA Biosciences Corporation Response to COVID-19 and Related Developments Table 81. Laboratory Corporation of America Holdings (LabCorp) Business Overview Table 82. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 83. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product Table 84. Laboratory Corporation of America Holdings (LabCorp) Response to COVID-19 and Related Developments Table 85. A&G Pharmaceutical Business Overview Table 86. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 87. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Product Table 88. A&G Pharmaceutical Response to COVID-19 and Related Developments Table 89. Affymetrix Inc Business Overview Table 90. Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 91. Affymetrix Inc Non-Invasive Cancer Diagnostics Product Table 92. Affymetrix Inc Response to COVID-19 and Related Developments Table 93. Precision Therapeutics Business Overview Table 94. Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 95. Precision Therapeutics Non-Invasive Cancer Diagnostics Product Table 96. Precision Therapeutics Response to COVID-19 and Related Developments List of Figures Figure 1. Non-Invasive Cancer Diagnostics Product Picture Figure 2. Non-Invasive Cancer Diagnostics Market Segmentation Figure 3. Research Objectives Figure 4. Research Process Figure 5. Data Triangulation Figure 6. Research Approach Figure 7. Commodity Prices-Metals Price Indices Figure 8. Commodity Prices- Precious Metal Price Indices Figure 9. Commodity Prices- Agricultural Raw Material Price Indices Figure 10. Commodity Prices- Food and Beverage Price Indices Figure 11. Commodity Prices- Fertilizer Price Indices Figure 12. Commodity Prices- Energy Price Indices Figure 13. G20+: Economic Policy Responses to COVID-19 Figure 14. Global Non-Invasive Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million) Figure 15. Global Non-Invasive Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%) Figure 16. Global Non-Invasive Cancer Diagnostics Market Size, Quarterly Growth, 2020-2021 (%) Figure 17. Global Non-Invasive Cancer Diagnostics Market Size, Market Share by Type, 2019 VS 2020 (%) Figure 18. Global Non-Invasive Cancer Diagnostics Market Size, Market Share by Application, 2019 VS 2020 (%) Figure 19. Global Non-Invasive Cancer Diagnostics Market Size Market Share by Region, 2019 VS 2020 (%) Figure 20. United States Composite PMI and GDP Figure 21. Eurozone Composite PMI and GDP Figure 22. Eurozone Core v. Periphery PMI Output Indices Figure 23. Core v. Periphery PMI Employment Indices Figure 24. UK Composite PMI and GDP Figure 25. Caixin China Composite Output Index Figure 26. Caixin China General Services Business Activity Index Figure 27. Japan Composite Output Index Figure 28. South Korea Manufacturing PMI Figure 29. India Composite Output Index Figure 30. ASEAN Manufacturing PMI Figure 31. By Region, Asia-Pacific Non-Invasive Cancer Diagnostics Market Size Market Share, 2019-2021

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global Fluorinating Reagents Market Report, History and Forecast 2015-2026

Market Analysis and Insights: Global Fluorinating Reagents Market Prior to COVID-19, the market for Fluorinating Reagents was anticipated to grow from US$ 43.26 million in 2020 to US$ 68.06 million by 2026; it is expected to grow at a CAGR of 7.85% d...

Global Electrostatic Sprayers Market Research Report 2020

Market Analysis and Insights: Global Electrostatic Sprayers Market The global Electrostatic Sprayers market was valued at US$ 16.05 million in 2020 and it is expected to reach US$ 59.52 million by the end of 2027, growing at a CAGR of -3.35% during 2...

Global Caviar Market Insights, Forecast to 2027

Market Analysis and Insights: Global Caviar Market In 2019, the global Caviar market size was increased to US$ 356.2 million, and it will reach US$ 531.45 million in 2027, growing at CAGR of 8.26% between 2020 and 2027. Global Caviar Scope and Segmen...

Global 3C Coating Market Report, History and Forecast 2015-2026

Market Analysis and Insights: Global 3C Coating Market In 2019, the global 3C coating market size was 1174.00 million USD and it is expected to reach 1147.76 million USD by the end of 2026, with a CAGR of 1.97% between 2020 and 2026. Global 3C Coatin...

COVID-19 Impact on Slim Cigarette Market, Global Research Reports 2020-2021

This report covers market size and forecasts of Slim Cigarette, including the following market information: Global Slim Cigarette Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) a (Billin Sticks) Global Slim Cigarette Marke...

Publisher: QY Research